- RESEARCH HIGHLIGHT
Small trial targeted liver proteins that play a part in the regulation of lipid levels.
Deposits of cholesterol (yellow; artist’s illustration) and other substances can clog up arteries. Credit: Springer Medizin/Science Photo Library
A single dose of a CRISPR gene-editing therapy reduces levels of harmful lipids — namely cholesterol and triglycerides — in the blood for at least one year1.
Access options
Access through your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
27,99 € / 30 days
cancel any time
Subscription info for Chinese customers
We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-026-02740-w